Department of Anesthesiology, University of Louisville, Paducah, KY, USA.
School of Medicine Anesthesiology and Perioperative Medicine, LSU Health Sciences Center, New Orleans, LA, USA.
Curr Pain Headache Rep. 2020 Apr 25;24(6):26. doi: 10.1007/s11916-020-00859-7.
Low back and lower extremity pain have been treated since 1901 with local anesthetics alone and since 1952 in combination with steroids. Over the years, multiple randomized controlled trials, systematic reviews with or without meta-analysis have been reaching discordant conclusions regarding the effectiveness of sodium chloride solution, local anesthetics, and steroids in managing spinal pain. Further, related to lack of understanding, multiple reviewers have considered local anesthetics including lidocaine and bupivacaine as equivalent to placebo based on theory that steroid is the only drug effective in the epidural space. In this review, we assessed effectiveness of epidurally administered bupivacaine with or without steroids to rule out misconceptions of placebo and to show the comparative effectiveness of epidural bupivacaine alone compared to epidural bupivacaine with steroids.
Multiple systematic reviews performed in assessing the effectiveness of epidural injections have converted epidurally administered lidocaine and bupivacaine to placebo. This led to inappropriate conclusions of lack of effectiveness of epidural local anesthetics with or without steroids as showing equal effectiveness when analyzed with conventional dual-arm meta-analysis. Thus, true placebo control trials with injection of an inactive substance into unrelated structures have been almost non-existent. Epidurally administered bupivacaine alone or with steroids are effective in managing low back and lower extremity pain. The findings of this review provide appropriate information of epidurally administered bupivacaine as an active agent (not a placebo) with level 1 evidence and almost equally effective as bupivacaine with steroids with level II evidence.
自 1901 年以来,人们一直单独使用局部麻醉剂治疗下腰痛和下肢痛,自 1952 年以来,人们一直联合使用局部麻醉剂和皮质类固醇治疗下腰痛和下肢痛。多年来,多项随机对照试验、有或无荟萃分析的系统评价得出了相互矛盾的结论,即氯化钠溶液、局部麻醉剂和皮质类固醇在治疗脊柱疼痛方面的有效性。此外,由于缺乏理解,多名评审员认为包括利多卡因和布比卡因在内的局部麻醉剂与安慰剂等效,其理论依据是皮质类固醇是唯一在硬膜外腔有效的药物。在本综述中,我们评估了硬膜外给予布比卡因加或不加皮质类固醇的疗效,以排除对安慰剂的误解,并展示单独硬膜外给予布比卡因与硬膜外给予布比卡因加皮质类固醇的疗效比较。
多项评估硬膜外注射疗效的系统评价将硬膜外给予的利多卡因和布比卡因转换为安慰剂。这导致了硬膜外局部麻醉剂加或不加皮质类固醇缺乏有效性的不当结论,因为当用传统的双臂荟萃分析进行分析时,它们显示出相同的疗效。因此,真正的安慰剂对照试验,即向无关结构注射非活性物质,几乎不存在。单独硬膜外给予布比卡因或联合皮质类固醇治疗下腰痛和下肢痛有效。本综述的结果提供了硬膜外给予布比卡因作为一种有效药物(而不是安慰剂)的适当信息,具有 1 级证据,与硬膜外给予布比卡因加皮质类固醇的疗效几乎相同,具有 2 级证据。